Sierra Oncology Inc. (SRRA) NASDAQ
$54.99 0.02 (0.04%)
Market Cap: -
As of 06/30/22 04:00 PM EDT. Market closed.
Sierra Oncology Inc. (SRRA)
NASDAQ
$54.99
0.02 (0.04%)
Market Cap: -
As of 06/30/22 04:00 PM EDT. Market closed.
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the ... read more
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Vivo Opportunity, LLC | Director | Jul 01, 2022 | Option Exercise | $55.00 | 431,947 | 23,757,085 | 0 | Jul 01, 2022, 04:59 PM |
Vivo Opportunity, LLC | Director | Jul 01, 2022 | Option Exercise | $55.00 | 2,735,853 | 150,471,915 | 0 | Jul 01, 2022, 04:59 PM |
Vivo Opportunity, LLC | Director | Jul 01, 2022 | Option Exercise | $55.00 | 161,712 | 8,894,160 | 0 | Jul 01, 2022, 04:59 PM |
ORBIMED ADVISORS LLC | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,964,770 | 108,062,350 | 0 | Jul 01, 2022, 04:50 PM |
Ashiya Mona | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,964,770 | 108,062,350 | 0 | Jul 01, 2022, 04:46 PM |
Aggarwal Gaurav | Director | Jul 01, 2022 | Option Exercise | $55.00 | 2,735,853 | 150,471,915 | 0 | Jul 01, 2022, 04:45 PM |
Sinclair Andrew | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,314,127 | 72,276,985 | 0 | Jul 01, 2022, 04:44 PM |
Klencke Barbara | Chief Medical Officer | Jul 01, 2022 | Option Exercise | $55.00 | 5,000 | 275,000 | 0 | Jul 01, 2022, 04:43 PM |
Klencke Barbara | Chief Medical Officer | Jul 01, 2022 | Option Exercise | $55.00 | 10,000 | 550,000 | 0 | Jul 01, 2022, 04:43 PM |
Allen Andrew R | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,650 | 90,750 | 0 | Jul 01, 2022, 04:38 PM |
Collard Craig A | Director | Jul 01, 2022 | Option Exercise | $55.00 | 13,500 | 742,500 | 0 | Jul 01, 2022, 04:37 PM |
DILLY STEPHEN GEORGE | CEO and President | Jul 01, 2022 | Option Exercise | $55.00 | 5,000 | 275,000 | 0 | Jul 01, 2022, 04:35 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Apr 06, 2022 | Option Exercise | $12.05 | 6,347 | 76,481 | 6,347 | Apr 07, 2022, 04:12 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Apr 05, 2022 | Option Exercise | $12.05 | 100 | 1,205 | 100 | Apr 07, 2022, 04:12 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Apr 06, 2022 | Sale | $37.25 | 6,347 | 236,409 | 0 | Apr 07, 2022, 04:12 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Apr 05, 2022 | Sale | $37.09 | 100 | 3,709 | 0 | Apr 07, 2022, 04:12 PM |
Thomson Mary Christina | General Counsel, CCO & Sec'y | Apr 04, 2022 | Option Exercise | $13.04 | 2,000 | 26,080 | 2,000 | Apr 04, 2022, 07:25 PM |
Thomson Mary Christina | General Counsel, CCO & Sec'y | Apr 04, 2022 | Sale | $35.14 | 2,000 | 70,277 | 0 | Apr 04, 2022, 07:25 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Mar 18, 2022 | Option Exercise | $12.05 | 100 | 1,205 | 100 | Mar 22, 2022, 04:15 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Mar 18, 2022 | Sale | $37.05 | 100 | 3,705 | 0 | Mar 22, 2022, 04:15 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Mar 17, 2022 | Option Exercise | $12.05 | 3,453 | 41,609 | 3,453 | Mar 17, 2022, 06:33 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Mar 17, 2022 | Sale | $37.06 | 3,453 | 127,954 | 0 | Mar 17, 2022, 06:33 PM |
Thomson Mary Christina | General Counsel, CCO & Sec'y | Mar 04, 2022 | Option Exercise | $13.04 | 2,000 | 26,080 | 2,000 | Mar 04, 2022, 04:12 PM |
Thomson Mary Christina | General Counsel, CCO & Sec'y | Mar 04, 2022 | Sale | $30.60 | 2,000 | 61,196 | 0 | Mar 04, 2022, 04:12 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Feb 07, 2022 | Option Exercise | $12.05 | 10,000 | 120,500 | 10,000 | Feb 08, 2022, 04:03 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Feb 07, 2022 | Sale | $32.32 | 10,000 | 323,225 | 0 | Feb 08, 2022, 04:03 PM |
Thomson Mary Christina | General Counsel, CCO & Sec'y | Feb 04, 2022 | Option Exercise | $13.04 | 2,000 | 26,080 | 2,000 | Feb 04, 2022, 04:08 PM |
Thomson Mary Christina | General Counsel, CCO & Sec'y | Feb 04, 2022 | Sale | $29.78 | 2,000 | 59,560 | 0 | Feb 04, 2022, 04:08 PM |
Longitude Capital Partners III, LLC | 10% Owner | Feb 02, 2022 | Buy | $27.00 | 175,000 | 4,725,000 | 175,000 | Feb 02, 2022, 09:25 PM |
Richardson Joshua | Director | Feb 02, 2022 | Buy | $27.00 | 175,000 | 4,725,000 | 175,000 | Feb 02, 2022, 09:24 PM |
Sinclair Andrew | Director | Jan 31, 2022 | Buy | $27.00 | 150,000 | 4,050,000 | 1,314,127 | Feb 01, 2022, 05:04 PM |
Sinclair Andrew | Director | Jan 28, 2022 | Option Exercise | $13.20 | 287,471 | 3,794,617 | 1,164,127 | Feb 01, 2022, 05:04 PM |
Abingworth LLP | 10% Owner | Jan 31, 2022 | Buy | $27.00 | 150,000 | 4,050,000 | 1,314,127 | Feb 01, 2022, 05:00 PM |
Abingworth LLP | 10% Owner | Jan 28, 2022 | Option Exercise | $13.20 | 287,471 | 3,794,617 | 1,164,127 | Feb 01, 2022, 05:00 PM |
Vivo Opportunity, LLC | 10% Owner | Jan 31, 2022 | Buy | $27.00 | 800,000 | 21,600,000 | 2,735,853 | Jan 31, 2022, 09:30 PM |
Aggarwal Gaurav | Director | Jan 31, 2022 | Buy | $27.00 | 800,000 | 21,600,000 | 2,735,853 | Jan 31, 2022, 06:47 PM |
Ashiya Mona | Director | Jan 26, 2022 | Option Exercise | $13.20 | 56,244 | 742,421 | 226,704 | Jan 28, 2022, 09:23 PM |
Ashiya Mona | Director | Jan 26, 2022 | Option Exercise | $13.20 | 431,206 | 5,691,919 | 1,511,362 | Jan 28, 2022, 09:23 PM |
ORBIMED ADVISORS LLC | Director | Jan 26, 2022 | Option Exercise | $13.20 | 56,244 | 742,421 | 226,704 | Jan 28, 2022, 09:22 PM |
ORBIMED ADVISORS LLC | Director | Jan 26, 2022 | Option Exercise | $13.20 | 431,206 | 5,691,919 | 1,511,362 | Jan 28, 2022, 09:22 PM |
Vivo Opportunity, LLC | 10% Owner | Jan 26, 2022 | Option Exercise | $13.20 | 480,277 | 6,339,656 | 1,935,853 | Jan 28, 2022, 08:12 PM |
Vivo Opportunity, LLC | 10% Owner | Jan 26, 2022 | Option Exercise | $13.20 | 24,996 | 329,947 | 161,712 | Jan 28, 2022, 08:12 PM |
Vivo Opportunity, LLC | 10% Owner | Jan 26, 2022 | Option Exercise | $13.20 | 107,164 | 1,414,565 | 431,947 | Jan 28, 2022, 08:12 PM |
Aggarwal Gaurav | Director | Jan 26, 2022 | Option Exercise | $13.20 | 480,277 | 6,339,656 | 1,935,853 | Jan 28, 2022, 07:53 PM |
Thomson Mary Christina | General Counsel & Secretary | Jan 26, 2022 | Option Exercise | $13.04 | 2,000 | 26,080 | 2,000 | Jan 28, 2022, 04:47 PM |
Thomson Mary Christina | General Counsel & Secretary | Jan 26, 2022 | Sale | $29.00 | 2,000 | 58,000 | 0 | Jan 28, 2022, 04:47 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Jan 26, 2022 | Option Exercise | $12.05 | 5,000 | 60,250 | 5,000 | Jan 28, 2022, 04:39 PM |
Turner William D. | Chief Reg & Tech Ops Officer | Jan 26, 2022 | Sale | $27.05 | 5,000 | 135,250 | 0 | Jan 28, 2022, 04:39 PM |
Longitude Capital Partners III, LLC | 10% Owner | Jan 25, 2022 | Option Exercise | $13.20 | 487,451 | 6,434,353 | 1,964,771 | Jan 27, 2022, 09:23 PM |
Richardson Joshua | Director | Jan 25, 2022 | Option Exercise | $13.20 | 487,451 | 6,434,353 | 1,964,771 | Jan 27, 2022, 09:22 PM |
Collard Craig A | Director | Nov 24, 2021 | Buy | $23.08 | 7,899 | 182,348 | 13,500 | Nov 24, 2021, 07:07 PM |
Collard Craig A | Director | Nov 23, 2021 | Buy | $22.94 | 5,601 | 128,515 | 5,601 | Nov 24, 2021, 07:07 PM |
DILLY STEPHEN GEORGE | CEO and President | May 19, 2021 | Buy | $17.83 | 5,000 | 89,150 | 5,000 | May 20, 2021, 06:59 PM |
Klencke Barbara | Chief Development Officer | Aug 18, 2020 | Buy | $12.22 | 5,950 | 72,710 | 10,000 | Aug 18, 2020, 08:16 PM |
Klencke Barbara | Chief Development Officer | Aug 18, 2020 | Buy | $12.25 | 3,325 | 40,738 | 5,000 | Aug 18, 2020, 08:16 PM |
Klencke Barbara | Chief Development Officer | Aug 23, 2019 | Buy | $0.44 | 108,000 | 47,380 | 162,000 | Aug 26, 2019, 05:07 PM |
Klencke Barbara | Chief Development Officer | Aug 22, 2019 | Buy | $0.45 | 54,000 | 24,295 | 54,000 | Aug 26, 2019, 05:07 PM |
Klencke Barbara | Chief Development Officer | Aug 22, 2019 | Buy | $0.43 | 67,000 | 28,964 | 67,000 | Aug 26, 2019, 05:07 PM |
Allen Andrew R | Director | Dec 10, 2018 | Buy | $1.64 | 66,000 | 108,240 | 66,000 | Dec 11, 2018, 05:38 PM |
You Angie | Chief Bus. & Strat. Officer | Mar 08, 2017 | Buy | $1.43 | 30,000 | 42,900 | 133,252 | Mar 09, 2017, 06:01 PM |
Topper James N | Director | Feb 14, 2017 | Buy | $1.35 | 5,925,926 | 8,000,000 | 5,925,926 | Feb 16, 2017, 05:11 PM |
Chapman Wendy | SVP Clinical Operations | Mar 22, 2016 | Option Exercise | $0.97 | 3,000 | 2,907 | 3,000 | Mar 24, 2016, 05:17 PM |
Chapman Wendy | SVP Clinical Operations | Mar 22, 2016 | Sale | $7.01 | 3,000 | 21,023 | 0 | Mar 24, 2016, 05:17 PM |
Chapman Wendy | SVP Clinical Operations | Feb 22, 2016 | Option Exercise | $0.97 | 3,000 | 2,907 | 3,000 | Feb 24, 2016, 05:07 PM |
Chapman Wendy | SVP Clinical Operations | Feb 22, 2016 | Sale | $7.06 | 3,000 | 21,180 | 0 | Feb 24, 2016, 05:07 PM |
Chapman Wendy | SVP Clinical Operations | Jan 22, 2016 | Option Exercise | $0.97 | 5,000 | 4,845 | 5,000 | Jan 25, 2016, 07:20 PM |
Chapman Wendy | SVP Clinical Operations | Jan 22, 2016 | Sale | $9.39 | 5,000 | 46,973 | 0 | Jan 25, 2016, 07:20 PM |
Rodigueza Wendi | Chief Scientific Officer | Jan 22, 2016 | Sale | $9.66 | 1,000 | 9,660 | 156,276 | Jan 22, 2016, 04:55 PM |
Rodigueza Wendi | Chief Scientific Officer | Jan 21, 2016 | Sale | $10.32 | 1,000 | 10,323 | 157,276 | Jan 22, 2016, 04:55 PM |
Rodigueza Wendi | Chief Scientific Officer | Jan 20, 2016 | Sale | $9.59 | 1,000 | 9,590 | 158,276 | Jan 22, 2016, 04:55 PM |
Glover Nicholas | CEO and President | Jan 15, 2016 | Option Exercise | $0.97 | 5,000 | 4,845 | 5,000 | Jan 19, 2016, 07:00 PM |
Glover Nicholas | CEO and President | Jan 15, 2016 | Sale | $10.04 | 5,000 | 50,223 | 0 | Jan 19, 2016, 07:00 PM |
Lovejoy Chandra D | SVP of Reg. Affairs & Quality | Jan 12, 2016 | Option Exercise | $0.97 | 7,551 | 7,317 | 20,973 | Jan 14, 2016, 05:16 PM |
Lovejoy Chandra D | SVP of Reg. Affairs & Quality | Jan 12, 2016 | Sale | $11.29 | 20,973 | 236,833 | 5,562 | Jan 14, 2016, 05:16 PM |
VIVO VENTURES VII, LLC | Former 10% holder | Jul 21, 2015 | Option Exercise | $5.22 | 2,324 | 12,120 | 2,218,270 | Jul 21, 2015, 07:06 PM |
VIVO VENTURES VII, LLC | Former 10% holder | Jul 21, 2015 | Option Exercise | $5.22 | 106,647 | 556,164 | 2,215,946 | Jul 21, 2015, 07:06 PM |
VIVO VENTURES VII, LLC | Former 10% holder | Jul 21, 2015 | Buy | $17.00 | 4,693 | 79,781 | 2,438,270 | Jul 21, 2015, 07:06 PM |
VIVO VENTURES VII, LLC | Former 10% holder | Jul 21, 2015 | Buy | $17.00 | 215,307 | 3,660,219 | 2,433,577 | Jul 21, 2015, 07:06 PM |
Vitangcol Alvin | Director | Jul 21, 2015 | Option Exercise | $5.22 | 39,889 | 208,021 | 798,762 | Jul 21, 2015, 07:05 PM |
Topper James N | Director | Jul 21, 2015 | Option Exercise | $5.22 | 96,589 | 503,712 | 1,966,195 | Jul 21, 2015, 07:04 PM |
Topper James N | Director | Jul 21, 2015 | Buy | $17.00 | 220,000 | 3,740,000 | 2,186,195 | Jul 21, 2015, 07:04 PM |
Thompson Peter A. | Director | Jul 21, 2015 | Option Exercise | $5.22 | 89,159 | 464,964 | 1,814,949 | Jul 21, 2015, 07:03 PM |
Thompson Peter A. | Director | Jul 21, 2015 | Buy | $17.00 | 175,000 | 2,975,000 | 1,989,949 | Jul 21, 2015, 07:03 PM |
Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 4,413 | 23,014 | 142,255 | Jul 21, 2015, 07:02 PM |
Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 819 | 4,271 | 65,779 | Jul 21, 2015, 07:02 PM |
Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 4,119 | 21,481 | 217,903 | Jul 21, 2015, 07:02 PM |
Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 1,552 | 8,094 | 770,045 | Jul 21, 2015, 07:02 PM |
ORBIMED ADVISORS LLC | Director | Jul 21, 2015 | Option Exercise | $5.22 | 89,159 | 464,964 | 1,814,949 | Jul 21, 2015, 07:00 PM |
ORBIMED ADVISORS LLC | Director | Jul 21, 2015 | Buy | $17.00 | 175,000 | 2,975,000 | 1,989,949 | Jul 21, 2015, 07:00 PM |
CHA ALBERT | Director | Jul 21, 2015 | Option Exercise | $5.22 | 106,647 | 556,164 | 2,215,946 | Jul 21, 2015, 06:59 PM |
CHA ALBERT | Director | Jul 21, 2015 | Option Exercise | $5.22 | 2,324 | 12,120 | 2,218,270 | Jul 21, 2015, 06:59 PM |
CHA ALBERT | Director | Jul 21, 2015 | Buy | $17.00 | 4,693 | 79,781 | 2,438,270 | Jul 21, 2015, 06:59 PM |
CHA ALBERT | Director | Jul 21, 2015 | Buy | $17.00 | 215,307 | 3,660,219 | 2,433,577 | Jul 21, 2015, 06:59 PM |
Owner | Relationship | Date | Value($) |
Vivo Opportunity, LLC | Director | 07/01/2022 | 23,757,085 |
Vivo Opportunity, LLC | Director | 07/01/2022 | 150,471,915 |
Vivo Opportunity, LLC | Director | 07/01/2022 | 8,894,160 |
ORBIMED ADVISORS LLC | Director | 07/01/2022 | 108,062,350 |
Ashiya Mona | Director | 07/01/2022 | 108,062,350 |
Aggarwal Gaurav | Director | 07/01/2022 | 150,471,915 |
Sinclair Andrew | Director | 07/01/2022 | 72,276,985 |
Klencke Barbara | Chief Medical Officer | 07/01/2022 | 275,000 |
Klencke Barbara | Chief Medical Officer | 07/01/2022 | 550,000 |
Allen Andrew R | Director | 07/01/2022 | 90,750 |
Collard Craig A | Director | 07/01/2022 | 742,500 |
DILLY STEPHEN GEORGE | CEO and President | 07/01/2022 | 275,000 |
Turner William D. | Chief Reg & Tech Ops Officer | 04/06/2022 | 76,481 |
Turner William D. | Chief Reg & Tech Ops Officer | 04/05/2022 | 1,205 |
Turner William D. | Chief Reg & Tech Ops Officer | 04/06/2022 | 236,409 |
Turner William D. | Chief Reg & Tech Ops Officer | 04/05/2022 | 3,709 |
Thomson Mary Christina | General Counsel, CCO & Sec'y | 04/04/2022 | 26,080 |
Thomson Mary Christina | General Counsel, CCO & Sec'y | 04/04/2022 | 70,277 |
Turner William D. | Chief Reg & Tech Ops Officer | 03/18/2022 | 1,205 |
Turner William D. | Chief Reg & Tech Ops Officer | 03/18/2022 | 3,705 |
Turner William D. | Chief Reg & Tech Ops Officer | 03/17/2022 | 41,609 |
Turner William D. | Chief Reg & Tech Ops Officer | 03/17/2022 | 127,954 |
Thomson Mary Christina | General Counsel, CCO & Sec'y | 03/04/2022 | 26,080 |
Thomson Mary Christina | General Counsel, CCO & Sec'y | 03/04/2022 | 61,196 |
Turner William D. | Chief Reg & Tech Ops Officer | 02/07/2022 | 120,500 |
Turner William D. | Chief Reg & Tech Ops Officer | 02/07/2022 | 323,225 |
Thomson Mary Christina | General Counsel, CCO & Sec'y | 02/04/2022 | 26,080 |
Thomson Mary Christina | General Counsel, CCO & Sec'y | 02/04/2022 | 59,560 |
Longitude Capital Partners III, LLC | 10% Owner | 02/02/2022 | 4,725,000 |
Richardson Joshua | Director | 02/02/2022 | 4,725,000 |
Sinclair Andrew | Director | 01/31/2022 | 4,050,000 |
Sinclair Andrew | Director | 01/28/2022 | 3,794,617 |
Abingworth LLP | 10% Owner | 01/31/2022 | 4,050,000 |
Abingworth LLP | 10% Owner | 01/28/2022 | 3,794,617 |
Vivo Opportunity, LLC | 10% Owner | 01/31/2022 | 21,600,000 |
Aggarwal Gaurav | Director | 01/31/2022 | 21,600,000 |
Ashiya Mona | Director | 01/26/2022 | 742,421 |
Ashiya Mona | Director | 01/26/2022 | 5,691,919 |
ORBIMED ADVISORS LLC | Director | 01/26/2022 | 742,421 |
ORBIMED ADVISORS LLC | Director | 01/26/2022 | 5,691,919 |
Vivo Opportunity, LLC | 10% Owner | 01/26/2022 | 6,339,656 |
Vivo Opportunity, LLC | 10% Owner | 01/26/2022 | 329,947 |
Vivo Opportunity, LLC | 10% Owner | 01/26/2022 | 1,414,565 |
Aggarwal Gaurav | Director | 01/26/2022 | 6,339,656 |
Thomson Mary Christina | General Counsel & Secretary | 01/26/2022 | 26,080 |
Thomson Mary Christina | General Counsel & Secretary | 01/26/2022 | 58,000 |
Turner William D. | Chief Reg & Tech Ops Officer | 01/26/2022 | 60,250 |
Turner William D. | Chief Reg & Tech Ops Officer | 01/26/2022 | 135,250 |
Longitude Capital Partners III, LLC | 10% Owner | 01/25/2022 | 6,434,353 |
Richardson Joshua | Director | 01/25/2022 | 6,434,353 |
Collard Craig A | Director | 11/24/2021 | 182,348 |
Collard Craig A | Director | 11/23/2021 | 128,515 |
DILLY STEPHEN GEORGE | CEO and President | 05/19/2021 | 89,150 |
Klencke Barbara | Chief Development Officer | 08/18/2020 | 72,710 |
Klencke Barbara | Chief Development Officer | 08/18/2020 | 40,738 |
Klencke Barbara | Chief Development Officer | 08/23/2019 | 47,380 |
Klencke Barbara | Chief Development Officer | 08/22/2019 | 24,295 |
Klencke Barbara | Chief Development Officer | 08/22/2019 | 28,964 |
Allen Andrew R | Director | 12/10/2018 | 108,240 |
You Angie | Chief Bus. & Strat. Officer | 03/08/2017 | 42,900 |
Topper James N | Director | 02/14/2017 | 8,000,000 |
Chapman Wendy | SVP Clinical Operations | 03/22/2016 | 2,907 |
Chapman Wendy | SVP Clinical Operations | 03/22/2016 | 21,023 |
Chapman Wendy | SVP Clinical Operations | 02/22/2016 | 2,907 |
Chapman Wendy | SVP Clinical Operations | 02/22/2016 | 21,180 |
Chapman Wendy | SVP Clinical Operations | 01/22/2016 | 4,845 |
Chapman Wendy | SVP Clinical Operations | 01/22/2016 | 46,973 |
Rodigueza Wendi | Chief Scientific Officer | 01/22/2016 | 9,660 |
Rodigueza Wendi | Chief Scientific Officer | 01/21/2016 | 10,323 |
Rodigueza Wendi | Chief Scientific Officer | 01/20/2016 | 9,590 |
Glover Nicholas | CEO and President | 01/15/2016 | 4,845 |
Glover Nicholas | CEO and President | 01/15/2016 | 50,223 |
Lovejoy Chandra D | SVP of Reg. Affairs & Quality | 01/12/2016 | 7,317 |
Lovejoy Chandra D | SVP of Reg. Affairs & Quality | 01/12/2016 | 236,833 |
VIVO VENTURES VII, LLC | Former 10% holder | 07/21/2015 | 12,120 |
VIVO VENTURES VII, LLC | Former 10% holder | 07/21/2015 | 556,164 |
VIVO VENTURES VII, LLC | Former 10% holder | 07/21/2015 | 79,781 |
VIVO VENTURES VII, LLC | Former 10% holder | 07/21/2015 | 3,660,219 |
Vitangcol Alvin | Director | 07/21/2015 | 208,021 |
Topper James N | Director | 07/21/2015 | 503,712 |
Topper James N | Director | 07/21/2015 | 3,740,000 |
Thompson Peter A. | Director | 07/21/2015 | 464,964 |
Thompson Peter A. | Director | 07/21/2015 | 2,975,000 |
Parfet Donald R | Chairman of the Board | 07/21/2015 | 23,014 |
Parfet Donald R | Chairman of the Board | 07/21/2015 | 4,271 |
Parfet Donald R | Chairman of the Board | 07/21/2015 | 21,481 |
Parfet Donald R | Chairman of the Board | 07/21/2015 | 8,094 |
ORBIMED ADVISORS LLC | Director | 07/21/2015 | 464,964 |
ORBIMED ADVISORS LLC | Director | 07/21/2015 | 2,975,000 |
CHA ALBERT | Director | 07/21/2015 | 556,164 |
CHA ALBERT | Director | 07/21/2015 | 12,120 |
CHA ALBERT | Director | 07/21/2015 | 79,781 |
CHA ALBERT | Director | 07/21/2015 | 3,660,219 |